Skip to main content
. 2001 Feb 15;7(1):120–125. doi: 10.3748/wjg.v7.i1.120

Figure 1.

Figure 1

Serum concentration of sICAM-1 in normal controls (n = 50), in patients with chronic hepatitis (CH, n = 62), cirrhosis (LC, n = 60), and hepatocellular carcinoma (HCC, n = 151). aP < 0.05, bP < 0.01.